Oxidative stress, insulin signaling, and diabetes
Top Cited Papers
- 1 March 2011
- journal article
- review article
- Published by Elsevier BV in Free Radical Biology & Medicine
- Vol. 50 (5), 567-575
- https://doi.org/10.1016/j.freeradbiomed.2010.12.006
Abstract
No abstract availableKeywords
This publication has 120 references indexed in Scilit:
- Safety and Efficacy of First-Line Bevacizumab Plus Chemotherapy in Elderly Patients with Advanced or Recurrent Nonsquamous Non-small Cell Lung Cancer: Safety of Avastin in Lung trial (MO19390)Journal of Thoracic Oncology, 2012
- Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?Annals of Oncology, 2010
- Thioredoxin glycation: A novel posttranslational modification that inhibits its antioxidant and organ protective actionsFree Radical Biology & Medicine, 2010
- Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)Annals of Oncology, 2010
- Role of Mitochondrial Dysfunction in Insulin ResistanceCirculation Research, 2008
- Slow-wave sleep and the risk of type 2 diabetes in humansProceedings of the National Academy of Sciences of the United States of America, 2008
- Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant miceJCI Insight, 2008
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Quantifying heterogeneity in a meta-analysisStatistics in Medicine, 2002
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001